Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:652745.
doi: 10.1155/2013/652745. Epub 2013 Apr 21.

Clonal Hypereosinophilia with ETV6 Rearrangement Evolving to T-Cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature

Affiliations

Clonal Hypereosinophilia with ETV6 Rearrangement Evolving to T-Cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature

Filipa Moita et al. Case Rep Hematol. 2013.

Abstract

Hypereosinophilia, either clonal or reactive, has been described in association with multiple hematological malignancies. We describe a case of a patient presenting with hypereosinophilia that evolved into T-cell lymphoblastic lymphoma. Complete remission was achieved with chemotherapy; however, hypereosinophilia recurred 5 months later in association with myeloblastic bone marrow infiltration and without evidence of lymphoblastic lymphoma relapse. Cytogenetic analysis of the bone marrow showed a complex translocation involving chromosomes 7, 12, and 16. A rearrangement of ETV6 gene (12p13) was demonstrated by FISH studies, thus confirming the clonality of this population. The association of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia has been described in disorders with FGFR1 rearrangements. We hypothesize that other clonal eosinophilic disorders lacking this rearrangement could behave in a similar fashion through different pathogenic mechanisms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bone marrow aspirate at relapse showing infiltration by myeloblasts, left shifted granulopoiesis, and marked hypereosinophilia.
Figure 2
Figure 2
Cytogenetics of the patient's bone marrow (a) G-banded karyotype showing 46,XX,t(7;12)(q22;p13),add(16)(p13); (b) fluorescence in situ hybridization using a dual-color break-apart probe showing rearrangement of ETV6 (12p13) (c) whole chromosome painting of chromosomes 7 (red) and 12 (green) showing 46,XX, del(7)(q22),der(12)t(7;12)(q22;p13)t(12;16)(p13;p13);der(16)t(12;16).

References

    1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. Lyon, France: IARC Press; 2008.
    1. Spitzer G, Garson OM. Lymphoblastic leukemia with marked eosinophilia: a report of two cases. Blood. 1973;42(3):377–384. - PubMed
    1. Ayyub M, Anwar M, Luqman M, Ali W, Bashir M, Bain BJ. A case of hypereosinophilic syndrome developing Hodgkin’s disease after 4 years. British Journal of Haematology. 2003;123(5):955–956. - PubMed
    1. Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood. 1998;92(5):1556–1564. - PubMed
    1. Roufosse F, Garaud S, De Leval L. Lymphoproliferative disorders associated with hypereosinophilia. Seminars in Hematology. 2012;49(2):138–148. - PubMed

LinkOut - more resources